Myeloid Cell Targeting Therapies: Budding Therapy Against Cancer

The global cancer burden is increasing rapidly with over 19 million new cancer cases and 10 million deaths reported in the year 2020. Given the rising prevalence, researchers have made significant efforts in discovering new approaches for the treatment of oncological diseases. With several programs having entered the clinical stages, myeloid cell targeting therapies have emerged as a novel strategy in the suite of cancer immunotherapy approaches.

All the blood and immune cells are formed from the hematopoietic stem cell, with multiple stepwise intermediates. The hematopoietic hierarchy is divided into two primary branches: the myeloid cells and lymphoid cells.

Leave a Reply